Subscribe to RSS
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1055/s-0041-1741087
Reducing Perinatal Mortality in India: Two-Years Results of the IRIA Fetal Radiology Samrakshan Program
![](https://www.thieme-connect.de/media/10.1055-s-00050590/202201/lookinside/thumbnails/10-1055-s-0041-1741087_2190912-1.jpg)
Abstract
Aim The aim of the study is to determine improvements in perinatal mortality at the end of the first 2 years from the initiation of the Samrakshan program of the Indian Radiological and Imaging Association.
Methods Samrakshan is a screening program of pregnant women that uses trimester-specific risk assessment protocols including maternal demographics, mean arterial pressure, and fetal Doppler studies to classify women as high risk or low risk for preterm preeclampsia (PE) and fetal growth restriction (FGR). Low dose aspirin 150 mg daily once at bedtime was started for pregnant women identified as high risk in the 11–136/7 weeks screening. The third-trimester screening focused on the staging of FGR and protocol-based management for childbirth and risk assessment for PE. Outcomes of childbirth including gestational age at delivery, development of PE, and perinatal mortality outcomes were collected.
Results Radiologists from 38 districts of 16 states of India participated in the Samrakshan program that screened 2,816 first trimester, 3,267 second trimester, and 3,272 third trimester pregnant women, respectively. At 2 years, preterm PE was identified in 2.76%, preterm births in 19.28%, abnormal Doppler study in 25.76% of third trimester pregnancies, and 75.32% of stage 1 FGR delivered at term. The neonatal mortality rate was 9.86/1,000 live births, perinatal mortality rate was 18.97/1,000 childbirths, and maternal mortality was 58/100,000 live births compared with 29.5, 36, and 113, respectively in 2016.
Conclusion Fetal Doppler integrated antenatal ultrasound studies in Samrakshan led to a significant reduction in preterm PE rates, preterm birth rates, and a significant improvement in mean birth weights. Perinatal, neonatal, and maternal mortality rates are significantly better than the targets for 2030 set by the Sustainable Development Goals-3.
Keywords
preeclampsia - fetal growth restriction - fetal Doppler - perinatal mortality - neonatal mortalityWork Attributed to
Indian Radiological & Imaging Association, IRIA House, C-5, Qutab Institutional Area, New Delhi 110016, India,
Financial Disclosures
None of the authors have any financial interests to disclose with respect to this study and manuscript.
Publication History
Article published online:
19 April 2022
© 2022. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 International Institute for Population Sciences (IIPS) and ICF. 2017. National Family Health Survey (NFHS-4), 2015–2016. Mumbai: IIPS;
- 2 Barker DJP. In utero programming of chronic disease. Clin Sci (Lond) 1998; 95 (02) 115-128
- 3 Barker DJ. Fetal origins of coronary heart disease. BMJ 1995; 311 (6998): 171-174
- 4 Stein CE, Fall CH, Kumaran K, Osmond C, Cox V, Barker DJP. Fetal growth and coronary heart disease in South India. Lancet 1996; 348 (9037): 1269-1273
- 5 Barker DJP, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993; 341 (8850): 938-941
- 6 Eriksson JG, Forsén T, Tuomilehto J, Winter PD, Osmond C, Barker DJP. Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ 1999; 318 (7181): 427-431
- 7 Rich-Edwards JW, Kleinman K, Michels KB. et al. Longitudinal study of birth weight and adult body mass index in predicting risk of coronary heart disease and stroke in women. BMJ 2005; 330 (7500): 1115-1118
- 8 Eriksson JG, Forsén T, Tuomilehto J, Osmond C, Barker DJP. Early growth and coronary heart disease in later life: longitudinal study. BMJ 2001; 322 (7292): 949-953
- 9 Bhargava SK, Sachdev HS, Fall CHD. et al. Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med 2004; 350 (09) 865-875
- 10 Eriksson JG, Forsén TJ, Osmond C, Barker DJP. Pathways of infant and childhood growth that lead to type 2 diabetes. Diabetes Care 2003; 26 (11) 3006-3010
- 11 Henriksen T, Clausen T. The fetal origins hypothesis: placental insufficiency and inheritance versus maternal malnutrition in well-nourished populations. Acta Obstet Gynecol Scand 2002; 81 (02) 112-114
- 12 Dekker GA, de Vries JIP, Doelitzsch PM. et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995; 173 (04) 1042-1048
- 13 Lorentzen B, Henriksen T. Plasma lipids and vascular dysfunction in preeclampsia. Semin Reprod Endocrinol 1998; 16 (01) 33-39
- 14 Kaaja R. Insulin resistance syndrome in preeclampsia. Semin Reprod Endocrinol 1998; 16 (01) 41-46
- 15 Prabhakaran D, Jeemon P, Roy A. Cardiovascular diseases in India: current epidemiology and future directions. Circulation 2016; 133 (16) 1605-1620
- 16 Unnikrishnan R, Anjana RM, Mohan V. Diabetes mellitus and its complications in India. Nat Rev Endocrinol 2016; 12 (06) 357-370
- 17 Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33 (03) 130-137
- 18 Bassani DG, Kumar R, Awasthi S. et al; Million Death Study Collaborators. Causes of neonatal and child mortality in India: a nationally representative mortality survey. Lancet 2010; 376 (9755): 1853-1860
- 19 Choorakuttil RM, Patel H, Bavaharan R. et al. Samrakshan: an Indian Radiological and Imaging Association program to reduce perinatal mortality in India. Indian J Radiol Imaging 2019; 29 (04) 412-417
- 20 Poon LC, Zymeri NA, Zamprakou A, Syngelaki A, Nicolaides KH. Protocol for measurement of mean arterial pressure at 11-13 weeks' gestation. Fetal Diagn Ther 2012; 31 (01) 42-48
- 21 Bhide A, Acharya G, Bilardo CM. et al. ISUOG practice guidelines: use of Doppler ultrasonography in obstetrics. Ultrasound Obstet Gynecol 2013; 41 (02) 233-239
- 22 Sotiriadis A, Hernandez-Andrade E, da Silva Costa F. et al; ISUOG CSC Pre-eclampsia Task Force. ISUOG Practice Guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia. Ultrasound Obstet Gynecol 2019; 53 (01) 7-22
- 23 O'Gorman N, Wright D, Syngelaki A. et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol 2016; 214 (01) 103.e1-103.e12
- 24 Rolnik DL, Wright D, Poon LC. et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 2017; 377 (07) 613-622
- 25 Choorakuttil RM for Team Samrakshan. The Samrakshan Screening Protocol for Pre-eclampsia in India. Journal of Fetal Radiology. 2020 . Accessed September 8, 2021 http://fetalradiology.in/2020/04/03/the-samrakshan-screening-protocol-for-pre-eclampsia-in-india/
- 26 Figueras F, Gratacós E. Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther 2014; 36 (02) 86-98
- 27 Bavaharan R, Choorakuttil RM, Ahuja B. et al. Routine 3rd Trimester Colour Doppler Ultrasound in Fetuses with Estimated Fetal Weight 10–50th centiles in India- Preliminary Results from the Samrakshan Program. Journal of Fetal Radiology. Accessed September 8, 2021: http://fetalradiology.in/2020/01/16/routine-3rd-trimester-colour-doppler-ultrasound-in-fetuses-with-estimated-fetal-weight-10-50th-centiles-in-india-preliminary-results-from-the-samrakshan-program/
- 28 Chaemsaithong P, Pooh RK, Zheng M. et al. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population. Am J Obstet Gynecol 2019; 221 (06) 650.e1-650.e16
- 29 Zwertbroek EF, Groen H, Fontanella F, Maggio L, Marchi L, Bilardo CM. Performance of the FMF first-trimester preeclampsia-screening algorithm in a high-risk population in the Netherlands. Fetal Diagn Ther 2021; 48 (02) 103-111
- 30 Chaemsaithong P, Sahota D, Pooh RK. et al. First-trimester pre-eclampsia biomarker profiles in Asian population: multicenter cohort study. Ultrasound Obstet Gynecol 2020; 56 (02) 206-214
- 31 Rezende KBC, Cunha AJLAD, Pritsivelis C, Faleiro EC, Amim Junior J, Bornia RG. How do maternal factors impact preeclampsia prediction in Brazilian population?. J Matern Fetal Neonatal Med 2019; 32 (07) 1051-1056
- 32 Kumar G, Choudhary TS, Srivastava A. et al. Utilisation, equity and determinants of full antenatal care in India: analysis from the National Family Health Survey 4. BMC Pregnancy Childbirth 2019; 19 (01) 327
- 33 Poon LC, Wright D, Rolnik DL. et al. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am J Obstet Gynecol 2017; 217 (05) 585.e1-585.e5
- 34 Sharma AK, Bhatla N. Aspirin for pregnancies at high risk for preterm pre-eclampsia. Natl Med J India 2018; 31 (01) 26-27
- 35 Kumar N, Das V, Agarwal A, Pandey A, Agrawal S, Singh A. Pilot Interventional Study comparing fetomaternal outcomes of 150 mg versus 75 mg aspirin starting between 11 and 14 weeks of pregnancy in patients with high risk of preeclampsia: a randomized control trial. J Obstet Gynaecol India 2020; 70 (01) 23-29
- 36 Wright D, Nicolaides KH. Aspirin delays the development of preeclampsia. Am J Obstet Gynecol 2019; 220 (06) 580.e1-580.e6
- 37 Oros D, Figueras F, Cruz-Martinez R, Meler E, Munmany M, Gratacos E. Longitudinal changes in uterine, umbilical and fetal cerebral Doppler indices in late-onset small-for-gestational age fetuses. Ultrasound Obstet Gynecol 2011; 37 (02) 191-195
- 38 Giles WB, Trudinger BJ, Baird PJ. Fetal umbilical artery flow velocity waveforms and placental resistance: pathological correlation. Br J Obstet Gynaecol 1985; 92 (01) 31-38
- 39 Eixarch E, Meler E, Iraola A. et al. Neurodevelopmental outcome in 2-year-old infants who were small-for-gestational age term fetuses with cerebral blood flow redistribution. Ultrasound Obstet Gynecol 2008; 32 (07) 894-899
- 40 Hershkovitz R, Kingdom JC, Geary M, Rodeck CH. Fetal cerebral blood flow redistribution in late gestation: identification of compromise in small fetuses with normal umbilical artery Doppler. Ultrasound Obstet Gynecol 2000; 15 (03) 209-212
- 41 Prior T, Mullins E, Bennett P, Kumar S. Prediction of intrapartum fetal compromise using the cerebroumbilical ratio: a prospective observational study. Am J Obstet Gynecol 2013; 208 (02) 124.e1-124.e6
- 42 Sirico A, Diemert A, Glosemeyer P, Hecher K. Prediction of adverse perinatal outcome by cerebroplacental ratio adjusted for estimated fetal weight. Ultrasound Obstet Gynecol 2018; 51 (03) 381-386
- 43 Sirico A, Rizzo G, Maruotti GM. et al. Does fetal macrosomia affect umbilical artery Doppler velocity waveforms in pregnancies complicated by gestational diabetes?. J Matern Fetal Neonatal Med 2016; 29 (20) 3266-3270
- 44 Sankar MJ, Neogi SB, Sharma J. et al. State of newborn health in India. J Perinatol 2016; 36 (s3) S3-S8